Background: The incidence of extranodal non-Hodgkin's lymphoma (NHL) is increasing
worldwide. The epidemiology of NHL in the Middle East is largely unknown. Patients and …

There is a wide variation in the prevalence of various subtypes of non-Hodgkin’s lymphoma
worldwide. The aim of this study was to determine the relative frequency of different …

Primary gastrointestinal lymphoma is the most common extranodal presentation of non-Hodgkin's
lymphoma. In this retrospective study, all cases of primary gastrointestinal lymphoma …

Objectives: To assess factors affecting engraftment among patients with lymphoproliferative
disorders treated with high dose-chemotherapy and autologous peripheral blood stem cell …

We conducted this study to describe the symptom burden among hospitalized patients with
cancer in a Kuwaiti cancer center. Twenty physical symptoms were assessed in 45 patients …

Introduction Venous thromboembolism (VTE) is a major cause of morbidity and mortality in
hospitalized patients with colon cancer. We assessed nationwide population-based trends in …

Objective: To describe histologic subtypes, clinical presentation and treatment outcome of
Hodgkin’s lymphoma in Kuwait. Subjects and Method: Patients older than 15 years, …

Introduction: Rituximab and 90Y-ibritumomab tiuxetan constitute a relatively new
radioimmunotherapeutic regimen for patients with CD20 low-grade non-Hodgkin’s lymphoma (NHL). …

1016 Evaluation of cyclic chemotherapy in non Hodgkin's lymphoma patients infected with
chronic hepatitis × Close The Infona portal uses cookies, ie strings of text saved by a browser …